GPCR oligomers in pharmacology and signaling

Molecular Brain

Volumn 4, Issue 1, 2011, Pages

  González Maeso, Javier ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LYSERGIDE; MESCALINE; PSILOCYBINE; DRUG; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN;

CONFORMATIONAL TRANSITION; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE;

ANIMALIA;

ANIMALS; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; MODELS, MOLECULAR; PHARMACEUTICAL PREPARATIONS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 79957516738     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-4-20     Document Type: Review

References (71)

1. The structure and function of G-protein-coupled receptors. DM Rosenbaum SG Rasmussen BK Kobilka, Nature 2009 459 356 363 10.1038/nature08144 19458711
2. The role of dimerisation in the cellular trafficking of G-protein-coupled receptors. G Milligan, Curr Opin Pharmacol 10 23 29
3. International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. JP Pin R Neubig M Bouvier L Devi M Filizola JA Javitch MJ Lohse G Milligan K Palczewski M Parmentier M Spedding, (Pubitemid 46335687)
4. Building a new conceptual framework for receptor heteromers. S Ferre R Baler M Bouvier MG Caron LA Devi T Durroux K Fuxe SR George JA Javitch MJ Lohse K Mackie G Milligan KD Pfleger JP Pin ND Volkow M Waldhoer AS Woods R Franco, Nat Chem Biol 2009 5 131 134 10.1038/nchembio0309-131 19219011
5. Class A GPCR heterodimers: evidence from binding studies. NJ Birdsall, Trends Pharmacol Sci 31 499 508
6. G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. G Milligan, Br J Pharmacol 2009 158 1 5 14 10.1111/j.1476-5381.2009.00169.x 19309353
7. Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics. L Albizu JL Moreno J Gonzalez-Maeso SC Sealfon, CNS Neurol Disord Drug Targets 9 636 650
8. Receptor heteromerization and drug discovery. R Rozenfeld LA Devi, Trends Pharmacol Sci 31 124 130
9. Aspects on receptor regulation and isoreceptor identification. LF Agnati K Fuxe I Zini P Lenzi T Hokfelt, Med Biol 1980 58 182 187 6167826 (Pubitemid 11164423)
10. New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram. LF Agnati K Fuxe M Zoli C Rondanini SO Ogren, Med Biol 1982 60 183 190 6128444 (Pubitemid 13253962)
11. Can different receptors interact directly with each other? NJ Birdsall, Trends Neurosci 1982 5 137 138
12. Beta-adrenergic receptors: evidence for negative cooperativity. LE Limbird PD Meyts RJ Lefkowitz, Biochem Biophys Res Commun 1975 64 1160 1168 10.1016/0006-291X(75)90815-3
13. Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high- and low-affinity agonist states. S Avissar G Amitai M Sokolovsky, Proc Natl Acad Sci USA 1983 80 156 159 10.1073/pnas.80.1.156 6571990 (Pubitemid 13221832)
14. The size of the mammalian lung beta 2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatography. CM Fraser JC Venter, Biochem Biophys Res Commun 1982 109 21 29 10.1016/0006-291X(82)91560-1 6297476 (Pubitemid 13072668)
15. Molecular size of the human platelet alpha 2-adrenergic receptor as determined by radiation inactivation. JC Venter JS Schaber DC U'Prichard CM Fraser, Biochem Biophys Res Commun 1983 116 1070 1075 10.1016/S0006-291X(83) 80251-4 6316964 (Pubitemid 14202689)
16. A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. RS Kent A De Lean RJ Lefkowitz, Mol Pharmacol 1980 17 14 23 6104284 (Pubitemid 10176266)
17. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. A De Lean JM Stadel RJ Lefkowitz, J Biol Chem 1980 255 7108 7117 6248546 (Pubitemid 11232874)
18. Evidence of paired M2 muscarinic receptors. LT Potter LA Ballesteros LH Bichajian CA Ferrendelli A Fisher HE Hanchett R Zhang, Mol Pharmacol 1991 39 211 221 1899905
19. The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography. P Seeman HC Guan O Civelli HH Van Tol RK Sunahara HB Niznik, Eur J Pharmacol 1992 227 139 146 10.1016/0922-4106(92)90121-B 1358662
20. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. L Farde FA Wiesel S Stone-Elander C Halldin AL Nordstrom H Hall G Sedvall, Arch GenPsychiatry 1990 47 213 219 (Pubitemid 20086672)
21. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. R Maggio Z Vogel J Wess, Proc Natl Acad Sci USA 1993 90 3103 3107 10.1073/pnas.90.7.3103 8385357 (Pubitemid 23113566)
22. gamma-aminobutyric acid(B) receptors: first of the functional metabotropic heterodimers. NG Bowery SJ Enna, J Pharmacol Exp Ther 2000 292 2 7 10604925 (Pubitemid 30026349)
23. G-protein-coupled receptor heterodimerization modulates receptor function. BA Jordan LA Devi, Nature 1999 399 697 700 10.1038/21441 10385123 (Pubitemid 29289066)
24. The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling. AR Calver MJ Robbins C Cosio SQ Rice AJ Babbs WD Hirst I Boyfield MD Wood RB Russell GW Price A Couve SJ Moss MN Pangalos, J Neurosci 2001 21 1203 1210 11160390 (Pubitemid 32128765)
25. Function of GB1 and GB2 subunits in G protein coupling of GABA(B) receptors. M Margeta-Mitrovic YN Jan LY Jan, Proc Natl Acad Sci USA 2001 98 14649 14654 10.1073/pnas.251554498 11724956 (Pubitemid 33121446)
26. Heterodimerization of a functional GABAB receptor is mediated by parallel coiled-coil alpha-helices. RA Kammerer S Frank T Schulthess R Landwehr A Lustig J Engel, Biochemistry 1999 38 13263 13269 10.1021/bi991018t 10529199
27. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies:application to GPCR oligomerization. D Maurel L Comps-Agrar C Brock ML Rives E Bourrier MA Ayoub H Bazin N Tinel T Durroux L Prezeau E Trinquet JP Pin, Nat Methods 2008 5 561 567 10.1038/nmeth.1213 18488035 (Pubitemid 351761765)
28. Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. J Kniazeff AS Bessis D Maurel H Ansanay L Prezeau JP Pin, Nat Struct Mol Biol 2004 11 706 713 10.1038/nsmb794 15235591 (Pubitemid 39014495)
29. Multiple interactions between transmembrane helices generate the oligomeric alpha1b-adrenoceptor. JJ Carrillo JF Lopez-Gimenez G Milligan, Mol Pharmacol 2004 66 1123 1137 10.1124/mol.104.001586 15304550 (Pubitemid 39411053)
30. The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function. JF Lopez-Gimenez M Canals JD Pediani G Milligan, Mol Pharmacol 2007 71 1015 1029 10.1124/mol.106.033035 17220353 (Pubitemid 46457006)
31. The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. W Guo L Shi JA Javitch, J Biol Chem 2003 278 4385 4388 10.1074/jbc.C200679200 12496294 (Pubitemid 36800928)
32. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. W Guo L Shi M Filizola H Weinstein JA Javitch, Proc Natl Acad Sci USA 2005 102 17495 17500 10.1073/pnas.0508950102 16301531 (Pubitemid 41740894)
33. Dopamine D2 receptors form higher order oligomers at physiological expression levels. W Guo E Urizar M Kralikova JC Mobarec L Shi M Filizola JA Javitch, Embo J 2008 27 2293 2304 10.1038/emboj.2008.153 18668123
34. Identification of a serotonin/glutamate receptor complex implicated in psychosis. J Gonzalez-Maeso RL Ang T Yuen P Chan NV Weisstaub JF Lopez-Gimenez M Zhou Y Okawa LF Callado G Milligan JA Gingrich M Filizola JJ Meana SC Sealfon, Nature 2008 452 93 97 10.1038/nature06612 18297054 (Pubitemid 351355090)
35. Psychedelics and schizophrenia. J Gonzalez-Maeso SC Sealfon, Trends Neurosci 2009 32 225 232 10.1016/j.tins.2008.12.005 19269047
36. Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. A Salahpour S Angers JF Mercier M Lagace S Marullo M Bouvier, J Biol Chem 2004 279 33390 33397 10.1074/jbc.M403363200 15155738 (Pubitemid 39062987)
37. Analysis of receptor oligomerization by FRAP microscopy. S Dorsch KN Klotz S Engelhardt MJ Lohse M Bunemann, Nat Methods 2009 6 225 230 10.1038/nmeth.1304 19234451
38. Instability of a class a G protein-coupled receptor oligomer interface. JM Fonseca NA Lambert, Mol Pharmacol 2009 75 1296 1299 10.1124/mol.108.053876 19273553
39. Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules. JA Hern AH Baig GI Mashanov B Birdsall JE Corrie S Lazareno JE Molloy NJ Birdsall, Proc Natl Acad Sci USA 107 2693 2698
40. mu-Opioid receptor and alpha 2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts. AM Gabilondo JJ Meana F Barturen M Sastre JA Garcia-Sevilla, Psychopharmacology (Berl) 1994 115 135 140 10.1007/BF02244763 (Pubitemid 24207773)
41. Increased density of mu-opioid receptors in the postmortem brain of suicide victims. AM Gabilondo JJ Meana JA Garcia-Sevilla, Brain Res 1995 682 245 250 10.1016/0006-8993(95)00333-L 7552322
42. Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors. J Gonzalez-Maeso R Rodriguez-Puertas JJ Meana JA Garcia-Sevilla J Guimon, Mol Psychiatry 2002 7 755 767 10.1038/sj.mp.4001067 12192620 (Pubitemid 34984953)
43. mu-opioid receptor and alpha2-adrenoceptor agonist stimulation of [35S]GTPgammaS binding to G-proteins in postmortem brains of opioid addicts. JJ Meana J Gonzalez-Maeso JA Garcia-Sevilla J Guimon, Mol Psychiatry 2000 5 308 315 10.1038/sj.mp.4000727 10889534 (Pubitemid 30438407)
44. alpha-Adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims. EM Valdizan R Diez-Alarcia J Gonzalez-Maeso F Pilar-Cuellar JA Garcia-Sevilla JJ Meana A Pazos, Biol Psychiatry 68 869 872
45. Functional interactions between mu opioid and alpha 2A-adrenergic receptors. BA Jordan I Gomes C Rios J Filipovska LA Devi, Mol Pharmacol 2003 64 1317 1324 10.1124/mol.64.6.1317 14645661 (Pubitemid 37532221)
46. Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling. JP Vilardaga VO Nikolaev K Lorenz S Ferrandon Z Zhuang MJ Lohse, Nat Chem Biol 2008 4 126 131 10.1038/nchembio.64 18193048
47. Hallucinogens Recruit Specific Cortical 5-HT(2A) Receptor-Mediated Signaling Pathways to Affect Behavior. J Gonzalez-Maeso NV Weisstaub M Zhou P Chan L Ivic R Ang A Lira M Bradley-Moore Y Ge Q Zhou SC Sealfon JA Gingrich, Neuron 2007 53 439 452 10.1016/j.neuron.2007.01.008 17270739 (Pubitemid 46161267)
48. Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2Areceptor agonists. JL Moreno TD Holloway L Albizu SC Sealfon J Gonzalez-Maeso, Neurosci Lett 2011 493 3 76 9 10.1016/j.neulet.2011.01.046 21276828
49. Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration. ML Rives C Vol Y Fukazawa N Tinel E Trinquet MA Ayoub R Shigemoto JP Pin L Prezeau, Embo J 2009 28 2195 2208 10.1038/emboj.2009.177 19590495
50. CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling. AC Magalhaes KD Holmes LB Dale L Comps-Agrar D Lee PN Yadav L Drysdale MO Poulter BL Roth JP Pin H Anisman SS Ferguson, Nat Neurosci 13 622 629
51. Ligand-regulated oligomerization of beta(2)-adrenoceptors in a model lipid bilayer. JJ Fung X Deupi L Pardo XJ Yao GA Velez-Ruiz BT Devree RK Sunahara BK Kobilka, Embo J 2009 28 3315 3328 10.1038/emboj.2009.267 19763081
52. The luteinizing hormone receptor. ML Dufau, Annu Rev Physiol 1998 60 461 496 10.1146/annurev.physiol.60.1.461 9558473 (Pubitemid 28157883)
53. Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. A Rivero-Muller YY Chou I Ji S Lajic AC Hanyaloglu K Jonas N Rahman TH Ji I Huhtaniemi, Proc Natl Acad Sci USA 107 2319 2324
54. Two defective heterozygous luteinizing hormone receptors can rescue hormone action. C Lee I Ji K Ryu Y Song PM Conn TH Ji, J Biol Chem 2002 277 15795 15800 10.1074/jbc.M111818200 11859079 (Pubitemid 34967856)
55. Structural requirements for mutational lutropin/choriogonadotropin receptor activation. K Sangkuhl A Schulz G Schultz T Schoneberg, J Biol Chem 2002 277 47748 47755 10.1074/jbc.M203491200 12356766 (Pubitemid 36159299)
56. Increased abundance of opioid receptor heteromers after chronic morphine administration. A Gupta J Mulder I Gomes R Rozenfeld I Bushlin E Ong M Lim E Maillet M Junek CM Cahill T Harkany LA Devi, Sci Signal 3 a54
57. Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. L Albizu M Cottet M Kralikova S Stoev R Seyer I Brabet T Roux H Bazin E Bourrier L Lamarque C Breton ML Rives A Newman J Javitch E Trinquet M Manning JP Pin B Mouillac T Durroux, Nat Chem Biol 6 587 594
58. Fluorescent agonists and antagonists for vasopressin/oxytocin G protein-coupled receptors: usefulness in ligand screening assays and receptor studies. B Mouillac M Manning T Durroux, Mini Rev Med Chem 2008 8 996 1005 10.2174/138955708785740607 18782052
59. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. S Ferre G von Euler B Johansson BB Fredholm K Fuxe, Proc Natl Acad Sci USA 1991 88 7238 7241 10.1073/pnas.88.16.7238 1678519 (Pubitemid 21915125)
60. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. B Wu EY Chien CD Mol G Fenalti W Liu V Katritch R Abagyan A Brooun P Wells FC Bi DJ Hamel P Kuhn TM Handel V Cherezov RC Stevens, Science 330 1066 1071
61. Crystal structure of rhodopsin: A G protein-coupled receptor. K Palczewski T Kumasaka T Hori CA Behnke H Motoshima BA Fox I Le Trong DC Teller T Okada RE Stenkamp M Yamamoto M Miyano, Science 2000 289 739 745 10.1126/science.289.5480.739 10926528 (Pubitemid 30650186)
62. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. SG Rasmussen HJ Choi DM Rosenbaum TS Kobilka FS Thian PC Edwards M Burghammer VR Ratnala R Sanishvili RF Fischetti GF Schertler WI Weis BK Kobilka, Nature 2007 450 383 387 10.1038/nature06325 17952055 (Pubitemid 350126755)
63. Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor. SG Rasmussen HJ Choi JJ Fung E Pardon P Casarosa PS Chae BT Devree DM Rosenbaum FS Thian TS Kobilka A Schnapp I Konetzki RK Sunahara SH Gellman A Pautsch J Steyaert WI Weis BK Kobilka, Nature 469 175 180
64. Heterotrimeric G-proteins: a short history. G Milligan E Kostenis, Br J Pharmacol 2006 147 Suppl 1 46 55 16402120
65. Structural basis of G protein-coupled receptor-G protein interactions. J Hu Y Wang X Zhang JR Lloyd JH Li J Karpiak S Costanzi J Wess, Nat Chem Biol 6 541 548
66. Heterotrimeric G protein activation by G-protein-coupled receptors. WM Oldham HE Hamm, Nat Rev Mol Cell Biol 2008 9 60 71 10.1038/nrm2299 18043707
67. Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Y Han IS Moreira E Urizar H Weinstein JA Javitch, Nat Chem Biol 2009 5 688 695 10.1038/nchembio.199 19648932
68. Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. TH Bayburt AJ Leitz G Xie DD Oprian SG Sligar, J Biol Chem 2007 282 14875 14881 10.1074/jbc.M701433200 17395586 (Pubitemid 47093370)
69. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. MR Whorton MP Bokoch SG Rasmussen B Huang RN Zare B Kobilka RK Sunahara, Proc Natl Acad Sci USA 2007 104 7682 7687 10.1073/pnas.0611448104 17452637 (Pubitemid 47185966)
70. Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. JP Vilardaga M Bunemann C Krasel M Castro MJ Lohse, Nat Biotechnol 2003 21 807 812 10.1038/nbt838 12808462 (Pubitemid 36791401)
71. Trans-activation between 7TM domains: implication in heterodimeric GABAB receptor activation. C Monnier H Tu E Bourrier C Vol L Lamarque E Trinquet JP Pin P Rondard, Embo J 30 32 42